Following Melinta Therapeutics?
Get the free weekly contract digest
The latest new contracts, like Melinta Therapeutics’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Contract Type
partnership
ParsippanyBiotechnologyTherapeuticsBiopharmaDescription
Melinta Therapeutics, LLC has joined the National Home Infusion Association (NHIA) Future of Infusion Advisory Council (FIAC). The FIAC is a strategic advisory group composed of manufacturing and service companies heavily invested in the home and alternate site infusion industry. The collaboration with NHIA and other organizations will help enhance continuity of care for patients requiring infusion therapies.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months